Espoir's Path To Affordable Protection For
Infectious Diseases & Oncology.
Our mission
Espoir Therapeutics: A Global Force for Affordable Health.
At Espoir Therapeutics, headquartered in Canada, our mission is to make lifesaving Glycoconjugate Vaccines accessible to all.
We do this by harnessing the unique synergy of Glycochemistry and Protein Biology.
GMP-Grade CRM197
Our Groundbreaking Work.
Pioneered the development of both research and GMP-Grade CRM197
CRM197 is a vital component in bacterial conjugate vaccines such as those for Pneumococcal, Meningitis, Hib, Shigella, etc
Also for vaccines that need the immunogenicity provided by the CRM197 carrier, whether against viral infections or in oncology.
Espoir developed ESP-CRM197, stands head and shoulders above the competition, offering unwavering quality and immunogenicity
Infrastructure
Strengths That Set Us Apart.
Our expertise in producing a pure and immunogenic CRM197 carrier
Our state-of-the-art laboratory in Montreal, Canada, paired with a world-class GMP manufacturing facility in Manesar, India, empowers us to translate vaccine concepts into clinical reality.
Conjugate Vaccine Carrier
A Partner In Progress.
We go beyond by assisting our partners in chemical conjugation and analytical services
Accelerate research and development efforts for both bio-generic and novel vaccines.
Espoir offers unparalleled advantages to commercial vaccine developers
Affordable Worldwide
Affordable
Vaccines For All
Highly competitive supply of CRM197 and comprehensive support at every stage of vaccine development
A mission to make affordable vaccines accessible to nations worldwide
Fortify immunization programs, safeguarding the health of communities across the globe.
Our Team
Meet The Team
We do this by harnessing the unique synergy of Glycochemistry and Protein Biology.
